Suppr超能文献

良性特发性眼睑痉挛患者的非运动症状与运动障碍之间的关系。

Relations between nonmotor manifestations and motor disorders in patients with benign essential blepharospasm.

机构信息

Department of Ophthalmology, Eye, Ear, Nose, and Throat Hospital of Fudan University, 83 Fenyang Road, Shanghai, 200031, China.

NHC Key Laboratory of Myopia (Fudan University), Laboratory of Myopia, Chinese Academy of Medical Sciences, 83 Fenyang Road, Shanghai, 200031, China.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2023 Dec;261(12):3615-3623. doi: 10.1007/s00417-023-06141-x. Epub 2023 Jun 21.

Abstract

PURPOSE

To evaluate the relations between nonmotor manifestations (dry eye, mood disorders, and sleep disturbance) and motor disorders in patients with benign essential blepharospasm (BEB), and to determine whether relieving motor disorders by botulinum neurotoxin can improve the nonmotor manifestations.

METHODS

In this prospective case series study, 123 BEB patients were enrolled for evaluations. Among them, 28 patients underwent botulinum neurotoxin therapy and attended another two postoperative visits at 1 month and 3 months. Motor severity was measured with Jankovic Rating Scale (JRS) and Blepharospasm Disability Index (BSDI). We assessed dry eye using OSDI questionnaire, Schirmer test, tear break-up time (TBUT), tear meniscus height, lipid layer thickness (LLT) and corneal fluorescence staining. Zung's Self-rating Anxiety and Depression Scale (SAS, SDS) and Pittsburgh Sleep Quality Index (PSQI) were for mood status and sleep quality evaluations.

RESULTS

Patients with dry eye or mood disorders had higher JRS scores (5.78 ± 1.13, 5.97 ± 1.30) than those without (5.12 ± 1.40, 5.50 ± 1.16; P = 0.039, 0.019, respectively). BSDI values of patients with sleep disturbance (14.61 ± 4.71) was higher than those without (11.89 ± 5.44, P = 0.006). Correlations were found between JRS, BSDI and SAS, SDS, PSQI, OSDI, TBUT. Botulinum neurotoxin effectively relieved JRS, BSDI and improved PSQI, OSDI, TBUT, LLT (8.11 ± 5.81, 21.77 ± 15.76, 5.04 ± 2.15 s, 79.61 ± 24.11 nm) at the 1-month visit compared to baseline (9.75 ± 5.60, 33.58 ± 13.27, 4.14 ± 2.21 s, 62.33 ± 22.01 nm; P = 0.006, < 0.001, = 0.027, < 0.001, respectively).

CONCLUSIONS

The BEB patients with dry eye, mood disorders, or sleep disturbance had more severe motor disorders. Motor severity was associated with the severity of the nonmotor manifestations. Relieving motor disorders by botulinum neurotoxin was effective in improving dry eye and sleep disturbance.

摘要

目的

评估良性特发性眼睑痉挛(BEB)患者的非运动症状(干眼、情绪障碍和睡眠障碍)与运动障碍之间的关系,并确定通过肉毒杆菌神经毒素缓解运动障碍是否能改善非运动症状。

方法

在这项前瞻性病例系列研究中,纳入了 123 名 BEB 患者进行评估。其中,28 名患者接受了肉毒杆菌神经毒素治疗,并在术后 1 个月和 3 个月时进行了另外两次随访。采用 Jankovic 评分量表(JRS)和眼睑痉挛残疾指数(BSDI)评估运动严重程度。我们使用 OSDI 问卷、Schirmer 测试、泪膜破裂时间(TBUT)、泪膜高度、脂质层厚度(LLT)和角膜荧光染色来评估干眼。Zung 的自评焦虑和抑郁量表(SAS、SDS)和匹兹堡睡眠质量指数(PSQI)用于评估情绪状态和睡眠质量。

结果

患有干眼或情绪障碍的患者 JRS 评分(5.78±1.13、5.97±1.30)高于无干眼或情绪障碍的患者(5.12±1.40、5.50±1.16;P=0.039、0.019)。睡眠障碍患者的 BSDI 值(14.61±4.71)高于无睡眠障碍的患者(11.89±5.44,P=0.006)。JRS、BSDI 与 SAS、SDS、PSQI、OSDI、TBUT 之间存在相关性。肉毒杆菌神经毒素治疗可有效缓解 JRS、BSDI,并改善 PSQI、OSDI、TBUT、LLT(治疗后 1 个月时的 8.11±5.81、21.77±15.76、5.04±2.15 s、79.61±24.11 nm),与基线相比(9.75±5.60、33.58±13.27、4.14±2.21 s、62.33±22.01 nm;P=0.006、<0.001、=0.027、<0.001)。

结论

患有干眼、情绪障碍或睡眠障碍的 BEB 患者运动障碍更严重。运动障碍严重程度与非运动症状的严重程度相关。肉毒杆菌神经毒素治疗缓解运动障碍可有效改善干眼和睡眠障碍。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验